Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients

OBJECTIVE: The primary objective of this study was to estimate the incidence of treatment failure (TF) to protease inhibitor monotherapies (PI/r-MT) with lopinavir/ritonavir (LPV/r) or darunavir/ritonavir (DRV/r). DESIGN: A multicenter cohort of HIV-infected patients with viral load (VL) ≤50 copies/...

Descripción completa

Detalles Bibliográficos
Autores principales: Gianotti, Nicola, Cozzi-Lepri, Alessandro, Antinori, Andrea, Castagna, Antonella, De Luca, Andrea, Celesia, Benedetto Maurizio, Galli, Massimo, Mussini, Cristina, Pinnetti, Carmela, Spagnuolo, Vincenzo, d’Arminio Monforte, Antonella, Ceccherini-Silberstein, Francesca, Andreoni, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5305227/
https://www.ncbi.nlm.nih.gov/pubmed/28192453
http://dx.doi.org/10.1371/journal.pone.0171611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5305227/
https://www.ncbi.nlm.nih.gov/pubmed/28192453
http://dx.doi.org/10.1371/journal.pone.0171611

Ejemplares similares